Pharmacokinetics Volume of distribution (Vd) 4.9 L/Kg Protein Binding Greater than 99% (primarily to albumin) Elimination half-life Not found in the product monograph Time to peak (Tmax) Ranges from between 1 to 49 days following multiple gluteal administrations of 960 mg Metabolism Primarily hepatic (CYP2D6 & CYP3A4) After multiple dose administration, dehydro-aripiprazole, the active metabolite, represents about 29% of aripirazole AUC in plasma Drug-drug Interactions Potential for Other Drugs to Affect Aripiprazole Aripiprazole is not a substrate of CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes
as all your favorite travel sayings go
The brand logo was printed in two languages Russian and English
Delaware: George Yocher, MS
J., Fowler, J
This concentrated delivery can lead to higher levels of nicotine in the system, making it harder to break the cycle